Yu Xia

4PUBLICATIONS
35CO-AUTHORS
Predictive and prognostic markersMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|May 27, 2026
Genomic instability drives POSTN<sup>+</sup> myofibroblasts via STING-WNT axis to promote immunosuppression and PARPi resistance in ovarian cancer.

|May 07, 2025
Mitigating T cell DNA damage during PARP inhibitor treatment enhances antitumor efficacy.

Jiahao Liu, Xiaofei Jiao, Wei Mu

|Feb 16, 2023
Suppression of GCH1 Sensitizes Ovarian Cancer and Breast Cancer to PARP Inhibitor.

Siyuan Wang, Yu Xia, Pu Huang

|Feb 13, 2023
Bepotastine Sensitizes Ovarian Cancer to PARP Inhibitors through Suppressing NF-κB-Triggered SASP in Cancer-Associated Fibroblasts.

Ping Jin, Xin Li, Yu Xia

Pageof 1

Frequent Collaborators

4 joint publications

Qinglei Gao

2 joint publications

Yong Fang

2 joint publications

Tian Fang

2 joint publications

Qing Zhong